BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3000397)

  • 1. [Aschoff's center of proliferation. Experience of the Gustave Roussy Institute].
    D'Amore E; Montes E; Le MG; Lacombe MJ; Bertin F; Castaigne D; Contesso G
    Ann Pathol; 1985; 5(3):173-82. PubMed ID: 3000397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleolar organizer regions distribution in fine needle aspiration cytological smears from breast lesions.
    Hasnan J; Jayaram G
    Malays J Pathol; 1996 Jun; 18(1):35-41. PubMed ID: 10879223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical ductal hyperplasia and ductal carcinoma in situ of the breast associated with perineural invasion.
    Gobbi H; Jensen RA; Simpson JF; Olson SJ; Page DL
    Hum Pathol; 2001 Aug; 32(8):785-90. PubMed ID: 11521220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
    Masood S; Loya A; Khalbuss W
    Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative aspiration cytology of breast tumors.
    Eisenberg AJ; Hajdu SI; Wilhelmus J; Melamed MR; Kinne D
    Acta Cytol; 1986; 30(2):135-46. PubMed ID: 3008470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Morphology of dysplasia and small cancer of the breast].
    Ermilova VD; Zolotarevskiĭ VB; Delektorskaia VV; Raĭkhlin NT
    Arkh Patol; 1985; 47(11):43-51. PubMed ID: 3004395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Histopathological diagnosis of papillary lesion of the breast].
    Akiyama F; Sakamoto G
    Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():32-5. PubMed ID: 7747989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
    Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR-Guided vacuum biopsy of 206 contrast-enhancing breast lesions.
    Perlet C; Schneider P; Amaya B; Grosse A; Sittek H; Reiser MF; Heywang-Köbrunner SH
    Rofo; 2002 Jan; 174(1):88-95. PubMed ID: 11793291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Automated microscopic image analysis and the prognosis of preneoplasms and carcinomas of the mammary gland].
    Guski H; Hufnagl P; Freitag A; Winzer KJ
    Gegenbaurs Morphol Jahrb; 1989; 135(1):39-53. PubMed ID: 2544475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Florid papillomatosis of the nipple. A study of 51 patients, including nine with mammary carcinoma.
    Rosen PP; Caicco JA
    Am J Surg Pathol; 1986 Feb; 10(2):87-101. PubMed ID: 3006526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Morphology, topography and growth pattern of benign proliferative breast lesions and pre-invasive cancers].
    Böcker W; Jarasch ED; Nagle EB; Höhne R
    Verh Dtsch Ges Pathol; 1985; 69():96-107. PubMed ID: 3006396
    [No Abstract]   [Full Text] [Related]  

  • 14. Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast.
    Carder PJ; Garvican J; Haigh I; Liston JC
    Histopathology; 2005 Mar; 46(3):320-7. PubMed ID: 15720418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Morphometric analysis of fibrocystic breast disease].
    Guski H; Freitag A; Hufnagl P; Voss K; Wenzelides K; Simon H
    Zentralbl Allg Pathol; 1986; 132(4):293-300. PubMed ID: 3026118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
    Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
    Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical apocrine adenosis of the breast: a clinicopathologic study of 37 patients with 8.7-year follow-up.
    Seidman JD; Ashton M; Lefkowitz M
    Cancer; 1996 Jun; 77(12):2529-37. PubMed ID: 8640702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammary lesions diagnosed as "papillary" by aspiration biopsy: 70 cases with follow-up.
    Simsir A; Waisman J; Thorner K; Cangiarella J
    Cancer; 2003 Jun; 99(3):156-65. PubMed ID: 12811856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situ.
    Rutstein LA; Johnson RR; Poller WR; Dabbs D; Groblewski J; Rakitt T; Tsung A; Kirchner T; Sumkin J; Keenan D; Soran A; Ahrendt G; Falk JS
    Breast J; 2007; 13(3):251-7. PubMed ID: 17461899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.